LATEST HEALTH NEWS
FDA has approved lumasiran subcutaneous injection to treat adults and children with primary hyperoxaluria type 1 (PH1)- an ultra- rare genetic disorder.
from Medindia Health News https://ift.tt/37jEkI1
FDA has approved lumasiran subcutaneous injection to treat adults and children with primary hyperoxaluria type 1 (PH1)- an ultra- rare genetic disorder.
from Medindia Health News https://ift.tt/37jEkI1
No comments
Thanks for comment via will connect you within 24 hours.